Sanjay Shrivastava - 11 Dec 2025 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Reporting relationship: Director
Issuer ticker: NVNO
Reported as of: 11 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Dec 2025, 20:10:34 UTC
Prior SEC filing: 26 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Sanjay Shrivastava

Key filing fact

Sanjay Shrivastava filed Form 4 for enVVeno Medical Corp (NVNO) on 15 Dec 2025.

Key facts

This page summarizes Sanjay Shrivastava's Form 4 filing for enVVeno Medical Corp (NVNO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Dec 2025, 20:10.

Change

Previous filing in this sequence was filed on 26 Dec 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001754588 Primary reporting owner

Shrivastava Sanjay

Relationship: Director
Address: C/O ENVVENO MEDICAL CORPORATION,, 70 DOPPLER, IRVINE
Signature: /s/ Sanjay Shrivastava
Signature date: 15 Dec 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NVNO transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +135,883
Change %
Price: $0.000000
Shares after: 135,883
Date: 11 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 135,883
Exercise price: $0.3250
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended . The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year.